CynosBio, Inc.

"To advance innovative therapies"

We, CynosBio, Inc., founded as a start-up company, which research, develop, manufacture and sell regenerative medicine, in 2015 at Hirosaki-city, Japan.
Our primary goal is to bring happiness to the lives of patients and their families. In order to realize it, our business focus is on the early advancement of innovative therapies based on regenerative medicine.

In this 21st century, numerous scientific technologies have dramatically progressed. As for the field of life science or medical science, genetics, cell-biology, protein-engineering and immuno-science are notable. We get many benefits from these sciences, such as various unique drugs and therapies using cell-culture technology.

To conduct clinical application thorough research and development of these technologies, the procedure is absolutely essential as a technology-oriented company and it is also our know-how. Recently, we have successfully received the manufacturing and sales approval from the Ministry of Health, Labour and Welfare in Japan for our regenerative medicine product “Sakracy (TR-09)”. This product, the cultivated autologous oral mucosal epithelial cell sheet, is grafted to severe ocular surface. It has been developed by academia.

Moreover, a clinical trial of the cultivated autologous chondrocyte is also in progress. This cellular matrix product (IK-01) is focused to osteoarthritis.

One of our advantages is a management skill of clinical development and sales marketing. In fact, we succussed introduction of seeds technology from academia, clinical application and its medical business.
At CynosBio, Inc., we believe and motivate that our products contribute to realize all people's healthy life and happy life with their smile.